南場　研一　業績集

英文業績（２００１年から現在まで）

IF (impact factor)：　2021年ISI Journal Citation Reportsより

 

本数

ＩＦ合計

一編あたり

First author

7

30.660

4.380

Corresponding author

29

63.507

2.190

Second author

10

42.955

4.296

その他

95

496.836

5.230

英文全業績

141

633.958

4.496

 

  1. Matsumoto K, Kase S, Namba K, Iwata D, Matsuno Y, Ishida S. A case of intraocular metastasis of lung cancer diagnosed using cell block preparation of vitreous humor. Cancer Diagn Progn. in press
  2. Nakai S, Takeuchi M, Usui Y, Namba K, Suzuki K, Harada Y, Kusuhara S, Kaburaki T, Tanaka R, Takeuchi M, Mizuki N, Nakai K, Goto H, Herbort CP Jr. Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study. Ocul Immunol Inflamm. Epub ahead of print
  3. Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, Ishida S. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt–Koyanagi–Harada Disease. Ocul Immunol Inflamm. Epub ahead of print
  4. Takase H, Goto H, Namba K, Mizuki N, Okada AA, Oguro N, Sonoda K, Tomita M, Keino H, Kezuka T, Kubono R, Mizuuchi K, Shibuya E, Takahashi H, Yanai R, Mochizuki M. Clinical Characteristics, Management, and Factors Associated with Poor Visual Prognosis of Acute Retinal Necrosis. Ocul Immunol Inflamm. Epub ahead of print.
  5. Fukutsu K, Kase S, Iwata D, Suzuki K, Namba K, Ishida S. The expression of matrix metalloproteinases in eyes with intraocular lymphoma. Ocul Immunol Inflamm. 2022; 30:1798-1802
  6. Iwata D, Namba K, Yamamoto T, Mizuuchi K, Saito W, Ohno S, Kitaichi N, Ishida S. Recent clinical features of intraocular inflammation in Hokkaido, Japan - comparison with the previous decade. Ocul Immunol Inflamm. 2022; 30: 848-854
  7. Kase S, Namba K, Iwata D, Mizuuchi K, Suzuki K, Ito T, Hase K, Kitaichi N, Ishida S. Diagnostic accuracy of cell block preparations and clinical features affecting it in vitreoretinal lymphoma. J Clin Med. 2022; 11: 1391
  8. Kijima R, Shinmei Y, Chin S, Kanaya R, Shinkai A, Ohguchi T, Nanba K, Ishida S. Long-term Outcomes of Modified 360-degree Suture Trabeculotomy for Uveitic Glaucoma Compared with Primary Open Angle Glaucoma. J Glaucoma. 2022; 31: 682-688
  9. Miyazaki D, Fukushima A, Uchio E, Shoji J, Namba K, Ebihara N, Takamura E, Fukuda K, Matsuda A, Okamoto S, Fukagawa K, Fujishima H, Ohno S, Ohashi Y; Japanese Society of Ocular Allergology, The Japanese Society of Allergology. Executive summary: Japanese guidelines for allergic conjunctival diseases 2021. Allergol Int. 2022; 71: 459-471
  10. Namba K, Kaburaki T, Tsuruga H, Ogawa Y, Iwashita E, Goto H. Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients. Ophthalmol Ther. 2022; 11:1147-1161
  11. Namba K, Takase H, Usui Y, Nitta F, Maruyama K, Kusuhara S, Takeuchi M, Azumi A, Yanai R, Kaneko Y, Hasegawa E, Nakai K, Tsuruga H, Morita K, Kaburaki T. Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis. Jpn J Ophthalmol. 2022; 66: 130-141
  12. Suzuki K, Ishihara M, Nanba K, Ohno S, Goto H, Takase H, Kawano S, Shibuya E, Hase K, Iwata D, Mizuuchi K, Kitaichi N, Mizuki N, Ishida S. Clinical features of ocular sarcoidosis: severe, refrectory, and prolonged inflammation. Jpn J Ophthalmol. 2022; 66: 447-454
  13. Suzuki K, Namba K, Hase K, Mizuuchi K, Iwata D, Ito T, Kitaichi N, Takase H, Ishida S. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep. 2022; 25: 101363
  14. Suzuki K, Namba K, Kase S, Ogino Y, Hase K, Iwata D, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma. BMC Ophthalmol. 2022; 22: 428
  15. Umazume A, Ohguro N, Okada AA, Namba K, Sonoda KH, Tsuruga H, Morita K, Goto H. Use of systemic corticosteroid in patients newly registered at a claims datebase with a diagnosis of non-infectious uveitis: result from a real-world claims database analysis. Jpn J Ophthalmol. 2022; 66: 394-404
  16. Weng X, Iwata D, Namba K, Suzuki K, Mizuuchi K, Nakamura H, Atsumi T, Ishida S. Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report. Am J Ophthalmol Case Rep. 2022; 25: 101333
  17. Yamashita Y, Hashimoto Y, Namba K, Mizuuchi K, Ishida S. Optic nerve head microcirculation in eyes with Vogt-Koyanagi-Harada disease accompanied by anterior ischemic optic neuropathy. Case Rep Ophthalmol. 2022; 12: 899-908
  18. Yokoi K, Namba K, Iwata D, Mizuuchi K, Hase K, Suzuki K, Ando R, Hirooka K, Sekine N, Kitaichi N, Hiraoka M, Ishida S. Fundus autofluorescence imaging in acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol Case Rep. 2022; 28: 101732
  19. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. 2021; 46: 1908-1916
  20. Kanaya R, Kijima R, Shinmei Y, Shinkai A, Ohguchi T, Namba K, Chin S, Ishida S. Surgical Outcomes of Trabeculectomy in Uveitic Glaucoma: A Long-Term, Single-Center, Retrospective Case-Control Study. J Ophthalmol. 2021; 2021: 5550776
  21. Kase S, Namba K, Iwata D, Mizuuchi K, Ito T, Hase K, Suzuki K, Onozawa M, Kitaichi N, Ishida S. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study. Cancer Diagnosis & Prognosis. 2021; 1: 69-75
  22. Sonoda KH, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H; JOIS (Japanese Ocular Inflammation Society) Uveitis Survey Working Group. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021; 65: 184-190
  23. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 971-978
  24. Suzuki K, Namba K, Mizuuchi K, Iwata D, Ito T, Hase K, Kitaichi N, Ishida S. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021; 65: 191-198
  25. Terada Y, Kaburaki T, Takase H, Goto H, Nakano S, Inoue Y, Maruyama K, Miyata K, Namba K, Sonoda KH, Kaneko Y, Numaga J, Fukushima M, Horiguchi N, Ide M, Ehara F, Miyazaki D, Hasegawa E, Mochizuki M. Distinguishing Features of Anterior Uveitis Caused by Herpes Simplex Virus, Varicella-Zoster Virus, and Cytomegalovirus. Am J Ophthalmol. 2021; 227: 191-200
  26. Umazume A, Ohguro N, Okada AA, Namba K, Sonoda K, Tsuruga H, Morita K, Goto H. Prevalence and incidence rates and treatment patterns of non-infectious uveitis in Japan: real-world data using a claims database. Jpn J Ophthalmol. 2021; 65: 657-665
  27. Balt J, Uehara O, Abiko Y, Jamyanjav B, Jav S, Nagasawa T, Horie Y, Mori M, Fujita M, Lennikov A, Ohta T, Hiraoka M, Iwata D, Namba K, Ohno S, Kitaichi N. Alteration of oral flora in Mongolian patients with Behcet’s disease – A multicenter study. Clin Exp Rheumatol. 2020; 127: 80-85
  28. Fukutsu K, Namba K, Iwata D, Mizuuchi K, Kase S, Suzuki K, Shimizu H, Shibata Y, Yamawaki F, Onozawa M, Ishida S. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging. BMC Ophthalmol. 2020; 20: 94
  29. Futakuchi A, Morimoto T, Ikeda Y, Tanihara H, Inoue T; ROCK-S study group collaborators (Aihara M, Arimura S, Fukuchi T, Higashide T, Honjo M, Inatani M, Inoue K, Ishida K, Ishikawa M, Iwao K, Kakimoto H, Kawase K, Kimura A, Kinoshita S, Kiuchi Y, Kokubun T, Maekawa S, Miyata K, Mori K, Nakamura S, Nakamura N, Nakamura M, Nakazawa T, Namba K, Nishida T, Ohguro N, Ohtani S, Okumichi H, Sakamoto M, Sawada A, Shiokawa M, Sotozono C, Suetake A, Sugiyama K, Takemoto Y, Tokumo K, Tomita G, Tsuzaki S, Udagawa S, Ueno M, Yokoyama Y, Yoshitomi T, Yuasa Y) . Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study. Sci Rep. 2020; 10: 10308
  30. Kase S, Namba K, Kanno-Okada H, Onozawa M, Hidaka D, Iwata D, Mizuuchi K, Fukuhara T, Fukuhara J, Kitaichi N, Matsuno Y, Ishida S. Immunohistochemical and immunocytochemical analyses in patients with vitreoretinal lymphoma. Ocul Immunol Inflamm. 2020; 28: 147–155
  31. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
  32. Meguro A, Ishihara M, Petrek M, Yamamoto K, Takeuchi M, Mrazek F, Kolek V, Benicka A, Yamane T, Shibuya E, Yoshino A, Isomoto A, Ota M, Yatsu K, Shijubo N, Nagai S, Yamaguchi E, Yamaguchi T, Namba K, Kaburaki T, Takase H, Morimoto SI, Hori J, Kono K, Goto H, Suda T, Ikushima S, Ando Y, Takenaka S, Takeuchi M, Yuasa T, Sugisaki K, Ohguro N, Hiraoka M, Kitaichi N, Sugiyama Y, Horita N, Asukata Y, Kawagoe T, Kimura I, Ishido M, Inoko H, Mochizuki M, Ohno S, Bahram S, Remmers EF, Kastner DL, Mizuki N. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis. Commun Biol. 2020; 3: 465
  33. Miyazaki D, Fukagawa K, Okamoto S, Fukushima A, Uchio E, Ebihara N, Shoji J, Namba K, Shimizu Y. Epidemiological aspects of allergic conjunctivitis. Allergol Int. 2020; 69: 487-495
  34. Miyazaki D, Shimizu D, Fukushima A, Ebihara N, Uchio E, Shoji J, Namba K, Inoue Y, Ohashi Y, Okamoto S, Takamura E, Fujishima H. Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseases. Jpn J Ophthalmol. 2020; 64: 568-576
  35. Miyazaki D, Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Satake Y, Shoji J, Namba K, Fukagawa K, Fukushima A, Fujishima H; Japanese Society of Ocular Allergology; Japanese Society of Allergology. Japanese guidelines for allergic conjunctival diseases 2020. Allergol Int. 2020; 69: 346-355
  36. Mizuuchi K, Saito W, Namba K, Ishida S. Multiple evanescent white dot syndrome and panuveitis: a case report. J Ophthalmic Inflamm Infect. 2020; 10: 26
  37. Nakano S, Tomaru Y, Kubota T, Takase H, Mochizuki M, Shimiizu N, Sugita S, Nakamuro T, Hosogai M, Nakatani Y, Sonoda KH, Hasegawa E, Takeda A, Myojin S, Yanai R, Uchi SH, Nagata K, Kaburaki T, Tanaka R, Goto H, Kezuka T, Usui Y, Yamakawa N, Fukuda K, Ishida W, Maruyama K, Hariya T, Namba K, Iwata D, Iwasaki T, Nejima R, Tomomatsu T, Aoki T, Kitaichi N, Horie Y, Takahashi M, Kurimoto Y, Hirami Y. Evaluation of a multiplex Strip PCR test for infectious uveitis: a prospective multi-center study. Am J Ophthalmol. 2020; 213: 252-259
  38. Sakono T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Ito T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Horita N, Ota M, Mizuki N. Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japan. PLoS One. 2020; 15: e0233464
  39. Goto H, Zako M, Namba K, Hashida N, Kaburaki T, Miyazaki M, Sonoda KH, Abe T, Mizuki N, Kamoi K, Brézin AP, Dick AD, Jaffe GJ, Nguyen QD, Inomata N, Kwatra NV, Camez A, Song AP, Kron M, Tari S, Ohno S. Adalimumab in active and inactive, non-infectious uveitis: global results from the VISUAL I and VISUAL II trials. Ocul Immunol Inflamm. 2019; 27: 40-50
  40. Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 1751-1758
  41. Miyazawa H, Fujita Y, Muramatsu K, Iwata H, Nomura T, Namba K, Hoshina D, Shimizu H. Refractory juvenile psoriatic uveitis without arthritis: A literature review. J Eur Acad Dermatol Venerol, 2019; 34: e173-e175
  42. Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA; International Workshop on Ocular Sarcoidosis Study Group(Accorinti M, A Acharya N, Asyari F, Babu K, Basu S, Biswas J, Bodaghi B, Chee SP, Chhabra R, Cowan CL, Goldstein DA, Goto H, Hwang YS, Ishihara M, Jabs DA, P Jones N, Kaburaki T, Kawashima H, Khairallah M, LeHoang P, Maruyama K, McCluskey P, Mochizuki M, Murray PI, Namba K, Ohguro N, Ohno S, Okada AA, Rao NA, Sakai T, Sheu SJ, Smith JR, Sonoda KH, Sukavatcharin S, Takase H, Tugal-Tutkun I, Gon Yu H, Zierhut M). Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019; 103: 1418-1422
  43. Ohno T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N. Association study of ARMC9 gene variants with Vogt-Koyanagi-Harada disease in Japanese patients. Ocul Immunol Inflamm. 2019; 27: 699-705
  44. Shibata Y, Kase S, Namba K, Ishida S. A case of nodular posterior scleritis simulating intraocular tumor. Int J Ophthalmol. 2019; 12: 685-688
  45. Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, Okamoto S. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis. Curr Eye Res. 2019; 44: 796-805
  46. Takeuchi M, Kanda T, Kaburaki T, Tanaka R, Namba K, Kamoi K, Maruyama K, Shibuya E, Mizuki N. Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study. Medicine (Baltimore). 2019; 98: e14668
  47. Uraki T, Namba K, Mizuuchi K, Iwata D, Ohno S, Kitaichi N, Ishida S. Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis. Am J Ophthalmol Case Rep. 2019; 14: 87-91
  48. Sakai M, Takase H, Namba K, Mizuuchi K, Iwata D, Ishida S. Two cases of cytomegalovirus panuveitis in immunocompetent patients. Am J Ophthalmol Case Rep. 2018; 10: 189-191
  49. Higashi K, Meguro A, Takeuchi M, Yamane T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Tsuneoka H, Keino H, Okada AA, akeda A, Fukuhara T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Mizuki N. Investigation of association between IL10 gene polymorphisms and Vogt-Koyanagi-Harada disease in a Japanese population. Ophthalmic Genet. 2017; 38: 187-189
  50. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. PLoS One. 2017; 12: e0172612
  51. Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D, Mizuki N, Ota M, Inoko H, Ishida S, Ohno S, Kitaichi N. HLA-B51 carriers are susceptible to ocular symptoms of Behcet disease and the association between the two becomes stronger towards the east along the Silk Road: a literature survey. Ocul Immunol Inflamm. 2017; 25: 37-40
  52. Iwata D, Mizuuchi K, Aoki K, Horie Y, Kase S, Namba K, Ohno S, Ishida S, Kitaichi N. Serial observation and clinical features of uveitis in Hokkaido, Japan. Ocul Immunol Inflamm. 2017; 25: S15-18
  53. Kanda A, Ishizuka ET, Shibata A, Matsumoto T, Toyofuku H, Noda K, Namba K, Ishida S. A novel single-strand RNAi therapeutic agent targeting (pro)renin receptor suppresses ocular inflammation. Mol Ther Nucleic Acids. 2017; 7: 116-126
  54. Kanno-Okada H, Takakuwa E, Tagawa Y, Kase S, Hatanaka KC, Hatanaka Y, Namba K, Mitsuhashi T, Matsuno Y. Cytopathologic findingsof cell block materials from the vitreous: Diagnostic distinction between intraocular lymphoma and non-lymphomatous diseases. Pathol Int. 2017; 67: 342-349
  55. Miyazaki D, Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Shoji J, Takamura E, Nakagawa Y, Namba K, Fujishima H. Steroid-sparing effect of 0.1% tacrolimus eye drop for treatment of shield ulcer and corneal epitheliopathy in refractory allergic ocular diseases. Ophthalmology. 2017; 124: 287-294
  56. Tagawa Y, Namba K, Nakazono Y, Iwata D, Ishida S. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. Allergol Int. 2017; 66: 338-343
  57. Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Kumagai N, Satake Y, Shoji J, Nakagawa Y, Namba K, Fukagawa K, Fukushima A, Fujishima H. Japanese Society of Allergology. Japanese guidelines for allergic conjunctival diseases 2017. Allergol Int. 2017; 66: 220-229
  58. Horie Y, Kitaichi N, Hijioka K, Sonoda K, Saishin Y, Kezuka T, Goto H, Takeuchi M, Nakamura S, Kimoto T, Shimakawa M, Kita M, Sugita S, Mochizuki M, Hori J, Iwata M, Shoji J, Fukuda M, Kaburaki T, Numaga J, Kawashima H, Fukushima A, Joko T, Takai N, Ozawa Y, Meguro A, Mizuki N, Namba K, Ishida S, Ohno S. Ocular Behçet’s disease is less complicated with allergic disorders. A nationwide survey in Japan. Clin Exp Rheumatol. 2016; 102: 1100-1105
  59. Kase S, Namba K, Iwata D, Mizuuchi K, Kitaichi N, Tagawa Y, Okada-Kanno H, Matsuno Y, Ishida S. Diagnostic efficacy of cell block method for vitreoretinal lymphoma. Diagn Pathol. 2016; 11: 29
  60. Sakurai Y, Namba K, Mizuuchi K, Nomura T, Ishida S. A case of severe panuveitis associated with psoriasis vulgaris successfully treated with infliximab. Case Report Ophthalmol. 2016; 7:191-194
  61. Satoh M, Namba K, Kitaichi N, Endo N, Kitamei H, Iwata D, Ohno S, Ishida S, Onoe K, Watarai H, Taniguchi M, Ishibashi T, Stein-Streilein J, Sonoda K, Kaer L V, Iwabuchi K. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Exp Eye Res. 2016; 153: 79-89
  62. Tagawa Y, Namba K, Mizuuchi K, Takemoto Y, Iwata D, Uno T, Fukuhara T, Hirooka K, Kitaichi N, Ohno S, Ishida S. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2016; 100: 473-477
  63. Takemoto Y, Namba K, Uno T, Mizuuchi K, Iwata D, Ohno S, Hirooka K, Hashimoto Y, Saito W, Sugiyama K, Ishida S. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy. Acta Ophthalmol. 2016; 94: e629-e636
  64. Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, Ishida S. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. BMC Ophthalmol. 2015; 15: 181
  65. Hirooka K, Saito W, Namba K, Takemoto Y, Mizuuchi K, Uno T, Tagawa Y, Hashimoto Y, Ishida S. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015; 253: 609-617
  66. Hase K, Namba K, Saito W, Ohno S, Ishida S. A case of tuberculous endophthalmitis successfully treated with vitrectomy followed by antituberculous agents. J Ophthalmic Inflamm Infect. 2015; 5: 14
  67. Lennikov A, Alekberova Z, Goloeva R, Kitaichi N, Denisov L, Namba K, Takeno M, Ishigatsubo Y, Mizuki N, Nasonov E, Ishida S, Ohno S. Single center study on ethnic and clinical features of Behcet’s disease in Moscow, Russia. Clin Rheumatol. 2015; 34: 321-327
  68. Namba K, Goto H, Kaburaki T, Kitaichi N, Mizuki N, Asukata Y, Fujino Y, Meguro A, Sakamoto S, Shibuya E, Yokoi K, Ohno S. A Major Review: Current Aspects of Ocular Behçet's Disease in Japan. Ocul Immunol Inflamm. 2015; 23: S1-S23
  69. Saito S, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Namba K, Ishida S. Acute zonal occult outer retinopathy in Japanese patients: Clinical features, visual function, and factors affecting visual function. PLoS One. 2015；10：e0125133
  70. Tagawa Y, Namba K, Ogasawara R, Kanno H, Ishida S. A case of mature natural killer-cell neoplasm manifesting multiple choroidal lesions – Primary intraocular NK-cell lymphoma. Case Rep Ophthalmol. 2015；21：380-384
  71. Takase H, Goto H, Mizuki N, Mizuuchi K, Namba K, Ohguro N, Okada A, Sonoda K, Tomita M, Keino H, Kezuka T, Kubono R, Shibuya E, Takahashi H, Yanai R, Mochizuki M. Development and Validation of new diagnostic criteria for acute retinal necrosis. Jpn J Ophthalmol. 2015; 59: 14-20
  72. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
  73. Fukushima A, Ohashi Y, Ebihara N, Uchio E, Okamoto S, Kumagai N, Shoji J, Takamura E, Nakagawa Y, Namba K, Fujishima H, Miyazaki D. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol. 2014; 98: 1023-1027
  74. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD), Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, Tzellos T, Zouboulis CC, Akhlagi M, Al-Dalaan A, Alekberova ZS, Ali AA, Altenburg A, Arromdee E, Baltaci M, Bastos M, Benamour S, Ben Ghorbel I, Boyvat A, Carvalho L, Chen W, Ben-Chetrit E, Chams-Davatchi C, Correia JA, Crespo J, Dias C, Dong Y, Paixão-Duarte F, Elmuntaser K, Elonakov AV, Graña Gil J, Haghdoost AA, Hayani RM, Houman H, Isayeva AR, Jamshidi AR, Kaklamanis P, Kumar A, Kyrgidis A, Madanat W, Nadji A, Namba K, Ohno S, Olivieri I, Vaz Patto J, Pipitone N, de Queiroz MV, Ramos F, Resende C, Rosa CM, Salvarani C, Serra MJ, Shahram F, Shams H, Sharquie KE, Sliti-Khanfir M, Tribolet de Abreu T, Vasconcelos C, Vedes J, Wechsler B, Cheng YK, Zhang Z, Ziaei N. The Iternational Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014; 28: 338-347
  75. Kaburaki T, Namba K, Sonoda KH, Kezuka T, Keino H, Fukuhara T, Kamoi K, Nakai K, Mizuki N, Ohguro N, Ohno S, Kitaichi N, Keino H, Okada AA, Watanabe T, Takeda A, Ishibashi T, Yawata K, Iwahashi C, Mochizuki M, Sugita S, Goto H, Takamoto M, Nakahara H, Kondo Y, Shibuya E, Kimura I. Behçet’s disease ocular attack score 24: Evaluation of ocular disease activity before and after initiation of infliximab. Jpn J Ophthalmol. 2014; 58: 120-130
  76. Lennikov A, Kitaichi N, Noda K, Mizuuchi K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis. 2014; 20: 171-177
  77. Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hijioka K, Shibuya E, Komae K, Hori J, Ohguro N, Sonoda KH, Mizuki N, Okada AA, Ishibashi T, Goto H, Mochizuki M. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study. Ophthalmology. 2014; 121: 1877-1884
  78. Iwahashi –Shima C, Azumi A, Ohguro N, Okada A. A, Kaburaki T, Goto H, Sonoda K, Namba K, Mizuki N, Mochizuki M. Acute retinal necrosis: factors associated with anatomic and visual outcomes. Jpn J Ophthalmol. 2013; 57: 98-103
  79. Jin XH, Namba K, Saito W, Iwata D, Ishida S. Bacterial endophthalmitis caused by an intraocular cilium in a patient under treatment with infliximab. J Ophthalmic Inflamm and Infect. 2013; 3:50
  80. Kase S, Namba K, Kitaichi N, Iwata D, Ohno S, Ishida S. Clinical features of human T lymphotropic virus type-1 associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013; 57: 379-384
  81. Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczek E, Lee EY, Song YW, Ohno S, Lee EB. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis. 2013; 72: 1510-1516
  82. Mizuuchi K, Kitaichi N, Namba K, Horie Y, Ishida S, Ohno S. Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2013; 57: 245-251
  83. Takemoto Y, Namba K, Mizuuchi K, Ohno S, Ishida S. Two cases of subfoveal choroidal neovascularization with tubulointerstitial nephritis and uveitis (TINU) syndrome. Eur J Ophthalmol. 2013; 23: 255-7
  84. Ebihara N, Ohashi Y, Fujishima H, Fukushima A, Nakagawa Y, Namba K, Okamoto S, Shoji J, Takamura E, Uchio E, Miyazaki D. Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. Allergol Int. 2012; 61: 275-282
  85. Horie Y, Meguro A, Kitaichi N, Lee E B, Kanda A, Noda K, Song Y W, Park K S, Namba K, Ota M, Inoko H, Mizuki N, Ishida S, Ohno S. Replication of a microsatellite genome-wide association study of Behcet disease in a Korean population. Rheumatology. 2012; 51: 983-986
  86. Ishijima K, Namba K, Ohno S, Mochizuki K, Ishida S. Intravitreal injection of bevacizumab in a case of occlusive retinal vasculitis accompanied with syphilitic intraocular inflammation. Case Report Ophthalmol. 2012; 3: 434-437
  87. Iwata D, Namba K, Mizuuchi K, Kitaichi N, Kase S, Takemoto Y, Ohno S, Ishida S. Correlation between elevation of serum antinuclear antibody titre and decreased therapeutic efficacy in the treatment of Behçet’s disease with infliximab. Graefes Arch Clin Exp Ophthalmol. 2012; 250: 1081-1087
  88. Kase S, Namba K, Jin XH, Kubota K, Ishida S. Spontaneous regression of intraocular lymphoma. Ophthalmology. 2012; 119: 1083-1084
  89. Kimura K, Usui Y, Goto H, Yoshikawa H, Sugita S, Namba K, Kaburagi T, Ohguro N, Okada A, Kawahara S, Azumi A, Sakamoto T, Furuta M, Takahira M, Takamura H, Oyama T, Takai N, Sakai T, Murakami A, Hayashi N, Ushida H, Kodama T, Otani T, Mizuki N, Kojima T, Maruyama K, Kubota T. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012; 56: 383-389
  90. Kitamei H, Namba K, Kitaichi N, Wakayama A, Ohno S, Ishida S. Chickenpox chorioretinitis with retinal exudates and periphlebitis. Case Report Ophthalmol. 2012; 3:180-184
  91. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  92. Okada AA, Goto H, Ohno S, Mochizuki M, Kitaichi N, Namba K, Keino H, Watanabe T, Ishibashi T, Ito T, Sonoda K, Nakai K, Ohguro N, Sugita S, Kezuka T, Kaburaki T, Takamoto M, Mizuki N. Multicenter study of infliximab for refractory uveoretinitis in Behcet's disease. Arch Ophthalmol. 2012; 130: 592-598
  93. Sakuyama K, Meguro A, Ota M, Ishihara M, Uemoto R, Ito H, Okada E, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Yuasa T, Ohno S, Inoko H, Mizuki N. Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients. Mol Vis. 2012; 18: 512-518
  94. Suzuki H, Ota M, Meguro A, Katsuyama Y, Kawagoe T, Ishihara M, Asukata Y, Takeuchi M, Ito N, Shibuya E, Nomura E, Uemoto R, Nishide T, Namba K, Kitaichi N Morimoto S, Kaburaki T, Ando Y, Takenaka S, Nakamura J, Saeki K, Ohno S, Inoko H, MIzuki N. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: Risk factors of BTNL2 gene polymorphisms and HLA class II alleles.  Invest Ophthalmol Vis Sci. 2012; 53: 7109-7115
  95. Ito R, Ota M, Meguro A, Katsuyama Y, Uemoto R, Nomura E, Nishide T, Kitaichi N, Horie Y, Namba K, Ohno S, Inoko H, MIzuki N. Investigation of Association between TLR9 Gene Polymorphisms and VKH in Japanese Patients. Ocul Immunol Inflamm. 2011; 19: 202-205
  96. Sato M, Kawagoe T, Meguro A, Ota M, Katsuyama Y, Ishihara M, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Ohno S, Inoko H, Mizuki N. Toll-like receptor2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population. Mol Vis. 2011; 17: 731-736
  97. Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Kumagai N, Satake Y, Shoji J, Nakagawa Y, Namba K, Fukagawa K, Fukushima A, Fujishima H; Japanese Society of Allergology: Japanese guideline for allergic conjunctival diseases. Allergol Int. 2011; 60:191-203
  98. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R/IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet. 2010; 42: 703-706
  99. Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y, Namba K, Okamoto S, Shoji J, Takamura E, Hayashi K., A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010; 26:165-74
  100. Iwata D, Kitaichi N, Ebihara A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, Onoé K. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B inhibitor dehydroxy methyl epoxyquinomicin in mice. Invest Ophthalmol Vis Sci. 2010; 51:2077-84
  101. Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba K, Morimoto J, Ebihara A, Kitamei, H, Yoshida K, Ishida S, Ohno S, Uede T, Onoé K, Iwabuchi K. Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA. Exp Eye Res. 2010; 90: 41-8
  102. Kitaichi N, Kitamura M, Namba K, Ishida S, Ohno S. Elevation of surfactant protein D, a pulmonary disease biomarker,in the sera of uveitis patients with sarcoidosis. Jpn J Ophthalmol. 2010; 54:81-4
  103. Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, Takemoto Y, Namba K,Yoshida K, Song YW, Park KS, Lee EB, Inoko H, Mizuki N, Ohno S.  Association of TLR4 polymorphisms with Behcet's disease in a Korean population.  Rheumatology (Oxford). 2009; 48(6):638-42
  104. Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, Satoh H, Ohno S.  Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2008; 86(8):902-7
  105. Dong Z, Namba K, Kitaichi N, Goda C, Kitamura M, Ohno S.  Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.  Jpn J Ophthalmol. 2008; 52(5):374-9
  106. Takemoto Y, Naruse T, Namba K, Kitaichi N, Ota M, Shindo Y, Mizuki N, Gul A, Madanat W, Chams H, Davatchi F, Inoko H, Ohno S, Kimura A.  Re-evaluation of heterogeneity in HLA-B*510101 associated with Behcet's disease.  Tissue Antigens. 2008; 72(4):347-53
  107. Kitamei H, Kitaichi N, Namba K, Kotake S, Goda C, Kitamura M, Miyazaki A, Ohno S.  Clinical features of intraocular inflammation in Hokkaido, Japan.  Acta Ophthalmol.  2009; 87(4):424-8
  108. Akahoshi M, Ishihara M, Namba K, Kitaichi N, Ando Y, Takenaka S, Ishida T,Ohno S, Mizuki N, Nakashima H, Shirakawa T.  Mutation screening of the CARD15 gene in sarcoidosis.  Tissue Antigens.  2008; 71(6):564-7
  109. Horie Y, Namba K, Kitaichi N, Ohno S.  Sister cases of Behcet's disease andVogt-Koyanagi-Harada disease.  Br J Ophthalmol.  2008; 92(3):433-4
  110. Mizuuchi K, Yanagawa Y, Iwabuchi K, Namba K, Kitaichi N, Ohno S, Onoe K.  KH2-D(d)-mediated upregulation of interleukin-4 production by natural killeT-cell and dendritic cell interaction.  Immunology. 2008; 124(1):102-11
  111. Horie Y, Kitaichi N, Takemoto Y, Namba K, Yoshida K, Hirose S, Hasumi Y, OtM, Inoko H, Mizuki N, Ohno S.  Polymorphism of IFN-gamma gene anVogt-Koyanagi-Harada disease. Mol Vis. 2007; 13:2334-8
  112. Kase S, Namba K, Horie Y, Kotake S, Ohno S.  Repeated exacerbations of ocularinflammation with vitreous hemorrhage in a patient with HLA-B27 associateuveitis.  J Med  Invest. 2007; 54(3-4):350-3
  113. Kitamura M, Iwabuchi K, Kitaichi N, Kon S, Kitamei H, Namba K, Yoshida KDenhardt DT, Rittling SR, Ohno S, Uede T, Onoe K.  Osteopontin aggravateexperimental autoimmune uveoretinitis in mice.  J Immunol. 2007 178(10):6567-72
  114. Kitamei H, Kitaichi N, Yoshida K, Nakai A, Fujimoto M, Kitamura M, IwabuchK, Miyazaki A, Namba K, Ohno S, Onoe K.  Association of heat shock protein 7induction and the amelioration of experimental autoimmune uveoretinitis in mice. Immunobiology. 2007; 212(1):11-8
  115. Matsuda A, Ebihara N, Kumagai N, Fukuda K, Ebe K, Hirano K, Sotozono C, TeM, Hasegawa K, Shimizu M, Tamari M, Namba K, Ohno S, Mizuki N, Ikezawa ZShirakawa T, Hamuro J, Kinoshita S.  Genetic polymorphisms in the promoter of theinterferon gamma receptor 1 gene are associated with atopic cataracts.  Invest Ophthalmol Vis Sci. 2007; 48(2):583-9
  116. Horie Y, Takemoto Y, Miyazaki A, Namba K, Kase S, Yoshida K, Ota M, Hasumi YInoko H, Mizuki N, Ohno S.  Tyrosinase gene family and Vogt-Koyanagi-Haraddisease in Japanese patients.  Mol Vis. 2006; 12:1601-5
  117. Saito W, Saito A, Namba K, Kase S, Shiratori M, Ohno S.  Chronic panuveitiand scleritis in a patient with cryptogenic organizing pneumonia.  Jpn J Ophthalmol. 2006; 50(6):558-61
  118. Kase S, Kitaichi N, Namba K, Miyazaki A, Yoshida K, Ishikura K, Ikeda MNakashima T, Ohno S. Elevation of serum Krebs von den Lunge-6 levels in patientswith tubulointerstitial nephritis and uveitis syndrome.  Am J Kidney Dis. 2006; 48(6):935-41
  119. Biros DJ, Namba K, Taylor AW. Alpha-MSH regulates protein ubiquitination in cells.  Cell Mol Biol (Noisy-le-grand). 2006; 52(2):33-8
  120. Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, KitamurM, Ohno S, Onoe K. Amelioration of experimental autoimmune uveoretinitis (EAUwith an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidindithiocarbamate.  J Leukoc Biol.  2006; 79(6):1193-201
  121. Kase S, Namba K, Kitaichi N, Ohno S. Epstein-Barr virus infected cells in thaqueous humour originated from nasal NK/T cell lymphoma.  Br J Ophthalmol. 2006; 90(2): 244-5
  122. Namba K, Sonoda KH, Kitamei H, Shiratori K, Ariyama A, Iwabuchi K, Onoe KSaniabadi AR, Inaba S, Ishibashi T, Ohno S. Granulocytapheresis in patients withrefractory ocular Behcet's disease. J Clin Apher. 2006; 21(2):121-8
  123. Kitamura M, Kitaichi N, Takeuchi M, Kitamei H, Namba K, Yamagishi SIIwabuchi K, Onoe K, Ohno S. Decrease in the glyceraldehyde derived advanceglycation end products in the sera of patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2005; 89(11):1407-9
  124. Goda C, Kotake S, Ichiishi A, Namba K, Kitaichi N, Ohno S. Clinical featuresin tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol. 2005; 140(4): 637-41
  125. Kase S, Saito W, Yoshida K, Namba K, Osaki M, Ohgami K, Shiratori K, KitaichN, Adachi H, Ito H, Ohno S. Expression of thymidine phosphorylase in choroidamalignant melanoma associated with neovascular glaucoma. Pathol Int. 2005; 55(9):569-73
  126. Kitaichi N, Ariga T, Kase S, Yoshida K, Namba K, Ohno S. Usefulness oquantifying serum KL-6 levels in the follow-up of uveitic patients witsarcoidosis. Graefes Arch Clin Exp Ophthalmol. 2006; 244(4): 433-7
  127. Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S. Comparative study of two sets of criteria for the diagnosis oVogt-Koyanagi-Harada's disease. Am J Ophthalmol. 2005; 139(6): 1080-5
  128. Kitaichi N, Namba K, Taylor AW. Inducible immune regulation followinautoimmune disease in the immune-privileged eye. J Leukoc Biol.  2005; 77(4): 496-502
  129. Kitaichi N, Kotake S, Shibuya H, Yamada Y, Chiba H, Namba K, Ohno S.  Increasof KL-6 in sera of uveitis patients with sarcoidosis. Graefes Arch Clin Exp Ophthalmol. 2003; 241(11): 879-83
  130. Kotake S, Namba K, Higashi K, Goda C, Ariga T, Ogawa A, Ohno S.  The change oclinical manifestations of patients with Behcet's disease in Japan.  Adv Exp Med Biol. 2003; 528: 83-4
  131. Namba K, Kitaichi N, Nishida T, Taylor AW. Induction of regulatory T cells bthe immunomodulating cytokines alpha-melanocyte-stimulating hormone antransforming growth factor-beta2. J Leukoc Biol. 2002; 72(5): 946-52
  132. Taylor AW, Yee DG, Nishida T, Namba K. Neuropeptide regulation of immunityThe immunosuppressive activity of alpha-melanocyte-stimulating hormon(alpha-MSH). Ann N Y Acad Sci. 2000; 917: 239-47
  133. Namba K, Ogasawara K, Kitaichi N, Morohashi T, Sasamoto Y, Kotake S, MatsudaH, Iwabuchi K, Iwabuchi C, Ohno S, Onoe K. Amelioration of experimentaautoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposomand anti-CD40 ligand monoclonal antibody. J Immunol.  2000; 165(6): 2962-9
  134. Ito D, Ogasawara K, Matsushita K, Morohashi T, Namba K, Matsuki N, KitaichN, Inuyama Y, Hosokawa M, Nakayama E, Iwabuchi K, Onoe K.  Effective priming ocytotoxic T lymphocyte precursors by subcutaneous administration of peptidantigens in liposomes accompanied by anti-CD40 and anti-CTLA-4 antibodies. Immunobiology. 2000; 201(5): 527-40
  135. Kitaichi N, Ogasawara K, Iwabuchi K, Nishihira J, Namba K, Onoe K, Konishi JKotake S, Matsuda H, Onoe K. Different influence of macrophage migratioinhibitory factor (MIF) in signal transduction pathway of various T cell subsets. Immunobiology. 2000; 201(3-4): 356-67
  136. Kitaichi N, Matsuda A, Kotake S, Namba K, Tagawa Y, Sasamoto Y, Ogasawara K,Iwabuchi K, Onoe K, Matsuda H, Nishihira J. Inhibition of experimental autoimmunuveoretinitis with anti-macrophage migration inhibitory factor antibodies. Curr Eye Res. 2000; 20(2): 109-14
  137. Matsuki N, Ogasawara K, Takami K, Namba K, Takahashi A, Fukui Y, Sasazuki T,Iwabuchi K, Good RA, Onoe K. Prevention of infection of influenza virus in DQmice, a human model, by a peptide vaccine prepared according to the cassetttheory. Vaccine. 1999; 17(9-10): 1161-8
  138. Kitaichi N, Kotake S, Sasamoto Y, Namba K, Matsuda A, Ogasawara K, Onoe KMatsuda H, Nishihira J. Prominent increase of macrophage migration inhibitorfactor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci.  1999; 40(1): 247-50
  139. Namba K, Ogasawara K, Kitaichi N, Matsuki N, Takahashi A, Sasamoto Y, KotakeS, Matsuda H, Iwabuchi K, Ohno S, Onoe K. Identification of a peptide inducinexperimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice.  Clin Exp Immunol. 1998; 111(2): 442-9
  140. Itoh Y, Kajino K, Ogasawara K, Takahashi A, Namba K, Negishi I, Matsuki NIwabuchi K, Kakinuma M, Good RA, Onoe K. Interaction of pigeon cytochromc-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule. Proc Natl Acad Sci U S A. 1997; 94(22): 12047-52
  141. Itoh Y, Kajino K, Ogasawara K, Katoh M, Namba K, Takami K, Iwabuchi KBraunstein NS, Onoe K. Determination of the allele-specific antigen-binding siteon I-Ak and I-Ab molecules. Eur J Immunol. 1996; 26(6): 1314-21